Record quarter for Allergan

Wednesday, November 12 2014 | 00 h 00 min | Financial News

In the third quarter of 2014, Allergan posted its strongest sales increase in the company’s history.

Allergan’s sales were CA$2 billion in the third quarter, up by 17.2% compared with the same period in 2013. Earnings totalled CA$350 million.

Pharmaceutical eyecare products (including Refresh and Restasis) showed a 14.2% sales increase to CA$915 million.

Allergan could not miss out on trumpeting its success, and perhaps it was thumbing its nose at Valeant. The latter is attempting to acquire Allergan and recently boasted its… second best quarter ever (see news clip from October 30).

For more information: http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=878172

Featured Posts

IRIS Wins 2024 Mercuriades Award

On Monday, May 6, at the 2024 Mercuriades Award gala ceremony, presented by the FCCQ (Fédération des chambres de commerce du Québec), IRIS received the "Investissement Québec Productivity Enhancement" award.

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

Anti-VEGF medications can prevent vision loss and even restore some vision for age-related macular degeneration (AMD) patients. However, they require frequent eye injections which cause anxiety and side effects.

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

L.V. Prasad Eye Institute (LVPEI) and the Centre for Ocular Research & Education (CORE) at the University of Waterloo have entered into a strategic partnership to advance vision science research and therapeutic development, as well as to enhance eye care delivery on a global scale.

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

IRIS Wins 2024 Mercuriades Award

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

IRIS Wins 2024 Mercuriades Award

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.

IRIS Wins 2024 Mercuriades Award

Learn More

Elegance and Boldness Combined: Introducing Victoria Beckham’s VB669S

The VB669S model from Victoria Beckham, with its rectangular shape and acetate frame, harmoniously combines elegance and boldness.

Clinical Trial Results for New Treatments for AMD and DME

LVPEI and CORE Sign Partnership Agreement for Vision Science and Therapeutic Development

Celebrating 25 Years of Frameless Elegance and UV Protection

Silhouette’s Titan Minimal Art Sun launches new sunglass models: ADARA, CALEUM (featured model) and GLENN featuring hyper-flexing temples and premium materials.